Structure and properties of pharmacologically active polymers
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Although the concept of using pharmacologically active macromolecular compounds as drugs is still regarded with much skepticism for both theoretical and practical reasons, interest in this field has grown in recent years because of the opportunity to take advantage of the specific properties of polymeric materials. For low molecular weight drugs, changes in structure often lead to a loss of specific activity. On the other hand, the properties of macromolecular drugs depend on the structure of the polymer used and this can be varied over a wide range by the incorporation of comonomer units, by the application of polymer‐analogous reactions, or by related structural changes. A new model is presented for pharmacologically active polymers which incorporates the possibility for continuous variation in (a) solubility and toxicity, (b) fixation and removal of active material, and (c) body distribution. Using the new model as a guide, examples of the synthesis and study of the biological activity of various macromolecular drugs are presented in order to emphasize the importance of this cooperative effort between polymer research and therapeutic problems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The drug-polymer conjugates were introduced in the early work by Helmut Ringsdorf in 1970s to improve drug solubility, toxicity, and body biodistribution, which was followed by extensive studies on the development of drug-polymer conjugates [143, 144].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [144]
Citations
Cites
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Chang, T. M. S. (1964) · Science · doi:10.1126/science.146.3643.524 · Cited by 1,011
Lysosomes in Biology and Pathology
Lagunoff, D. (1974) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1974.03230160059035 · Cited by 887
AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGES
Allison, A. C., Harington, J. S., & Birbeck, M. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.2.141 · Cited by 871
FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE
Boneu, B., Abbal, M., Plante, J., & Bierme, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92650-1 · Cited by 716
de Duve, C. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470715314.ch1 · Cited by 473
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 401
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Ryser, H. J.-P. (1968) · Science · doi:10.1126/science.159.3813.390 · Cited by 288
Research works printed but not linked: 20
- Lee H., 1971, Handbook for Surgery and Artificial Organs
- Kabaiwanow W., 1972, Plaste Kaut., 19, 886
- Wessel W., 1971, Arzeim. Forsch., 21, 1468
- Ryser H. J. P., 1970, Proc. Fourth Int. Cong. Pharm., 3, 96
- 1965, Silikose Forsch., 6, 213
- Ferruti P., 1966, Med. Lav., 57, 481
- V.Hofmann dissertation University of Mainz 1975.
- Burger A., 1970, Medicinal Chemistry, 1185
- Donaruma L. G., 1974, Prog. Polym. Sci., 4, 18
- G.Franzmann dissertation University of Mainz 1975.
- H.Morawetzet al. in press.
- Ringsdorf H., 1967, Strahlentherapie, 132, 627
- Busch H., 1961, Cancer Res., 21, 271
- H.Ritter dissertation University of Mainz 1975.
- M.Przybylski dissertation University of Mainz 1975.
- Jacob S. W., 1971, Dimethylsulfoxide
- V.Hofmann H.Ringsdorf andG.Muacevic Makromol. Chem. in press.
- Jacques P. J., 1966, Rev. Quest. Sci., 27, 99
- Jacques P. J., 1969, Lysosomes in Biology and Pathology, 395
- Szekerke M., 1972, Neoplasma, 19, 211
Cited by
Items 701–800 of 1,000
Chafi, N., Kolli, M., Vergnaud, J. M., & Monthéard, J. P. (1991) · Journal of Applied Polymer Science · doi:10.1002/app.1991.070431007 · Cited by 10
Jacobson, K. A., Verlander, M. S., Rosenkranz, R. P., Melmon, K. L., & Goodman, M. (1983) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1983.tb02095.x · Cited by 10
Syntheses and antitumor activities of polymers containing amino acid and 5-fluorouracil moieties
Park, J., Ha, C., & Cho, W. (1999) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/(sici)1099-0518(19990601)37:11<1643::aid-pola9>3.0.co;2-2 · Cited by 10
Pharmakologisch‐aktive polymere, 19. Polymere mit kovalent gebundenem streptomycinsulfat
Hofmann, V., Ringsdorf, H., Seganova, A., & Wagner, W. (1979) · Die Makromolekulare Chemie · doi:10.1002/macp.1979.021800331 · Cited by 10
Self-citationSimple Fabrication of Glutathione-Responsive PEGylated Micellar Nanocarriers for Dual Drugs Delivery
Zhao, S., Wang, D., Zhang, K., & Zhang, H. (2015) · International Journal of Polymeric Materials · doi:10.1080/00914037.2015.1030649 · Cited by 9
Yang, J., Wang, H., Yin, Z., Zhang, S., Xu, J., & Zhang, X. (2022) · Science China Chemistry · doi:10.1007/s11426-022-1311-3 · Cited by 9
Drug–polymer conjugates: Challenges, opportunities, and future prospects in clinical trials
Bajwa, N., Mahal, S., Singh, P. A., Jyoti, K., Dewangan, P., Madan, J., & Baldi, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91663-9.00011-4 · Cited by 9
Characterization of naproxen–polymer conjugates for drug-delivery
Forte, G., Chiarotto, I., Giannicchi, I., Loreto, M. A., Martinelli, A., Micci, R., Pepi, F., Rossi, S., Salvitti, C., Stringaro, A., et al. (2015) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2015.1108637 · Cited by 9
“The optimal goal is the creation of a smart functionalized polymer able to accomplish multiple tasks through a rational design of its structure, according to the Ringsdorf ’s model of polymer-based drug delivery systems.[4,5] Among the effects induced by a polymeric prodrug, the enhanced permeability and retention phe…”
BackgroundSurface-Immobilized Biomolecules
Frey, S. J., Hoffman, A. S., Hubbell, J. A., & Kane, R. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816137-1.00036-2 · Cited by 10
Recent advance in self‐assembled polymeric nanomedicines for gaseous signaling molecule delivery
van der Vlies, A. J., Yamane, S., & Hasegawa, U. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1934 · Cited by 9
Introducing Targeting Units or pH-Releasable Immunodrugs into Core-Clickable Nanogels
Heck, A. G., Schwiertz, D., Lantzberg, B., Nguyen, H., Forster, R., Scherger, M., Opatz, T., Ginderachter, J. A. V., & Nuhn, L. (2024) · European Polymer Journal · doi:10.1016/j.eurpolymj.2024.113150 · Cited by 9
Synthesis and Biological In Vitro Evaluation of Novel PEG−Psoralen Conjugates
Bettìo, F., Canevari, M., Marzano, C., Bordin, F., Guiotto, A., Greco, F., Duncan, R., & Veronese, F. M. (2006) · Biomacromolecules · doi:10.1021/bm060760n · Cited by 9
STUDIES ON THE INTERACTION OF DNA AND WATER-SOLUBLE POLYMER-SUPPORTED SCHIFF BASE COMPLEX
Wang, Y., Xiao, Y., Zhang, C.-X., & Wang, R. (2001) · Journal of Macromolecular Science Part A · doi:10.1081/ma-100107131 · Cited by 9
“Especially interesting are investigations of pharmacologically active polymers (polymer drug) which by themselves may be active as drugs or alternatively may be used as carries for normal pharmaceutical agents [6-9].”
BackgroundKim, T., Kim, K., Park, G. H., Choi, J. H., Lee, S., Kang, H. J., Lee, J. Y., & Kim, J. (2009) · Macromolecular Research · doi:10.1007/bf03218613 · Cited by 9
Patil, V., Gada, K. S., Panwar, R., Majewski, S., Tekabe, Y., Varvarigou, A. D., & Khaw, B. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.818675 · Cited by 9
“are limited by non-specific toxicity to normal cells and tissues [1].”
BackgroundNanoparticles: Scope in Drug Delivery
Tanwar, M., Meena, J., & Meena, L. S. (2014) · Wiley eBooks · doi:10.1002/9781118774052.ch14 · Cited by 9
Siddique, A. B., An, J. W., Kim, H. J., Park, H., Lee, Y. J., Lee, G. C., Kang, H. J., Lee, J. Y., Kim, S., & Kim, J. (2016) · Macromolecular Research · doi:10.1007/s13233-017-5004-1 · Cited by 9
Grebinişan, D., Holban, M. N., Lionte, C., Peptu, C., Şunel, V., Popa, M., & Desbrières, J. (2013) · Polymer-Plastics Technology and Engineering · doi:10.1080/03602559.2013.798824 · Cited by 9
“Polymer-drug conjugates as association of active principles to polymer supports by chemical binding were first mentioned by Ringsdorf in 1975([1]).”
BackgroundNovel triazolyl derivatives for acidic release of amines
Delatouche, R., Mondon, M., Gil, A., Frapper, G., Bachmann, C., & Bertrand, P. (2010) · Tetrahedron · doi:10.1016/j.tet.2010.11.026 · Cited by 9
Macromolecular Prodrugs of Small Molecules
Marinaro, W. A., & Stella, V. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-49785-3_27 · Cited by 9
Hénin, O., Boustta, M., Domurado, M., Coudane, J., Domurado, D., & Vert, M. (1998) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159801300103 · Cited by 9
Polymer-Drug Conjugates: Targeting Cancer
Duncan, R. (2002) · Springer eBooks · doi:10.1007/978-1-4757-4627-3_10 · Cited by 9
Andreani, F., Salatelli, E., & Ferruti, P. (1986) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391158600100107 · Cited by 9
Pitha, J. (1981) · Springer eBooks · doi:10.1007/978-1-4757-9510-3_15 · Cited by 9
Manecke, G., & Schlegel, R. (1976) · Die Makromolekulare Chemie · doi:10.1002/macp.1976.021771107 · Cited by 9
Román, J. S., Gallardo, A., & Levenfeld, B. (1994) · Macromolecular Symposia · doi:10.1002/masy.19940840118 · Cited by 9
Preface PEGylated protein conjugates: A new class of therapeutics for the 21st century
Duncan, R., & Veronese, F. M. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8679-5_1 · Cited by 9
“Pioneering work began to emerge in the 1960s and 1970s that lay the foundations for a clearly defined chemical and biological rational for the design of polymeric drugs [13, 19, 20], polymer–protein conjugates [1–8], polymerdrug conjugates [ 21 ] and block copolymer micelles [19].”
BackgroundShirinichi, F., Ibrahim, T., Rodriguez, M., & Sun, H. R. (2022) · Journal of Polymer Science · doi:10.1002/pol.20220614 · Cited by 8
Supramolecular Assembly and Thermogelation Strategies Using Peptide–Polymer Conjugates
Pascouau, C., Schweitzer, M., & Besenius, P. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00031 · Cited by 8
Fibril aggregates of the poly(glutamic acid)–drug conjugate
Lai, J., & Huang, Y. (2015) · RSC Advances · doi:10.1039/c5ra06755c · Cited by 8
Macromolecular Conjugates of Methotrexate, Ferrocene and Platinum in Cancer Chemotherapy
Mufula, A. I., & Neuse, E. W. (2011) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-011-9497-3 · Cited by 8
Impact of Modern Technology on the Development of Natural-based Products
Arifin, S. F., Al-Shami, A. M., Omar, S. S. S., Jalil, A. A., Khalid, K. A., & Hadi, H. A. (2020) · Journal of Ayurvedic and Herbal Medicine · doi:10.31254/jahm.2019.5404 · Cited by 11
Benington, L. R., Mo, J., Li, M., Rajan, G. P., Locher, C., & Lim, L. Y. (2024) · Pharmaceuticals · doi:10.3390/ph17020247 · Cited by 8
Pharmaceutical Nanotechnology: Overcoming Drug Delivery Challenges in Contemporary Medicine
Ganta, S., Singh, A., Coleman, T. P., Williams, D., & Amiji, M. M. (2014) · Nanostructure science and technology · doi:10.1007/978-1-4614-2140-5_10 · Cited by 11
Pharmaceutical Applications of Maleic Anhydride/Acid Copolymers
Popescu, I. (2015) · Wiley eBooks · doi:10.1002/9781119041412.ch10 · Cited by 8
Polymer–Drug Conjugates for Targeted Drug Delivery
Mohanty, A. K., Dilnawaz, F., Mohanta, G. P., & Sahoo, S. K. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_12 · Cited by 8
The Role of Nanoparticles in the Diagnosis and Treatment of Diseases
Munir, M., Hussain, S., Anwar, R., Waqas, M., & Ali, J. (2020) · Scientific Inquiry and Review · doi:10.32350/sir/2020/43/981 · Cited by 8
“But nanoparticles using biodegradable polymers are more effective in eradicating problems [21].”
BackgroundNanomaterials Derived From Phosphorus-Containing Polymers
Koseva, N. S., Mitova, V. A., Todorova, Z., & Tsacheva, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813932-5.00005-4 · Cited by 8
Nanoparticulate system for cancer therapy: An updated review
Kumar, D., & Sharma, P. (2018) · International Journal of Nanomaterials Nanotechnology and Nanomedicine · doi:10.17352/2455-3492.000027 · Cited by 8
“The concept of polymer conjugates for anticancer agent was proposed in 1975 [17].”
BackgroundMacromolecular Conjugates of 4- and 8-Aminoquinoline Compounds
Aderibigbe, B. A., & Neuse, E. W. (2011) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-011-9616-1 · Cited by 8
MACROMOLECULAR CARRIERS FOR DRUG TARGETING
Schacht, E. H., Winne, K. D., Hoste, K., & Vansteenkiste, S. O. (2003) · Elsevier eBooks · doi:10.1016/b978-012744481-9/50038-6 · Cited by 8
Macromolecular prodrugs: blood interactions and targeting
O’Mullane, J., & Daw, A. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90035-c · Cited by 8
Accumulation of Polyvinylpyrrolidone within the Inflamed Paws of Adjuvant-induced Arthritic Rats
Seale, L., Love, W. G., Amos, N., Williams, B. D., & Kellaway, I. W. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb14354.x · Cited by 8
“wt (Ringsdorf 1975); this would also facilitate the increased tissue uptake of the 360 kDa PVP observed here.”
BackgroundMinko, T., Khandare, J. J., & Jayant, S. (2007) · Wiley eBooks · doi:10.1002/9783527631421.ch61 · Cited by 8
Carriers for drugs and enzymes based on copolymers of allyl glycidyl ether with acrylamide
Pitha, J., Zawadzki, S., & Hughes, B. A. (1982) · Die Makromolekulare Chemie · doi:10.1002/macp.1982.021830403 · Cited by 8
Synthesis and properties of water‐soluble polyphosphazenes with aminoalcoholic functions
Crommen, J. H. L., Vandorpe, J., & Schacht, E. H. (1992) · Die Makromolekulare Chemie · doi:10.1002/macp.1992.021930602 · Cited by 8
Bauduin, G., Bessière, J., Bondon, D., Martel, J., & Pietrasanta, Y. (1981) · Die Makromolekulare Chemie · doi:10.1002/macp.1981.021821204 · Cited by 8
Deng, X., Yuan, M., Xiong, C., & Li, X. (1999) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19990822)73:8<1401::aid-app7>3.0.co;2-m · Cited by 41
Interaction of synthetic polymers with components of the living materials
Kálal, J. (1979) · Die Makromolekulare Chemie · doi:10.1002/macp.1979.020021979114 · Cited by 8
Aslan, B., Han, H. D., Lopez‐Berestein, G., & Sood, A. K. (2016) · Springer eBooks · doi:10.1007/978-94-017-9780-1_71 · Cited by 8
Sobieraj, J., Strzelecka, K., Sobczak, M., & Olędzka, E. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s458907 · Cited by 7
“173 The type of bonding between the polymer carrier and the drug is a critical parameter for the controlled drug release characteristic, as it determines conjugates’ susceptibility to hydrolytic and enzymatic degradation.”
BackgroundKisomi, M. F., Yadegar, A., Shekari, T., Amin, M., Llopis‐Lorente, A., Liu, C., Haririan, I., Aghdaei, H. A., Shokrgozar, M. A., Zali, M. R., et al. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2391910 · Cited by 8
“The use of biopolymers for the delivery of bioactive agents was first described by Ringsdorf in 1975 [81].”
Engineered 1,6-heptadiynes based polymeric prodrug system for anticancer drug delivery
Kumar, P., Patra, D., Halder, R., & Shunmugam, R. (2024) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2024.2418851 · Cited by 7
“[21] This development plays a great role in field of drug delivery.”
Applications of Polymer Bioconjugates
Opsteen, J. A., & van Hest, J. C. M. (2007) · Wiley eBooks · doi:10.1002/9783527631421.ch63 · Cited by 8
Kenawy, E., El-Khalafy, S. H., Abosharaf, H. A., El‐nshar, E. M., Ghazy, A. R., & Azaam, M. M. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300090 · Cited by 7
Special Dosage Forms and Drug Delivery Systems
Mohapatra, S. K., & Dash, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99796-6.00018-7 · Cited by 7
Hashimoto, T., & Yamaoka, T. (2006) · Springer eBooks · doi:10.1007/4-431-27879-6_4 · Cited by 7
Braunová, A., Pechar, M., & Ulbrich, K. (2004) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc20041643 · Cited by 7
Polyacrylamide and related polymers
Kavitha, A. A., & Anilkumar, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00008-8 · Cited by 7
Avcıbaşı, U., Ateş, B., Ünak, P., Gümüşer, G., Gülcemal, S., Ol, K. K., Akgöl, S., & Tekin, V. (2019) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2019.108872 · Cited by 7
Preparation and Dynamic Behavior of Protein-Polymer Complexes Formed with Polymer-Binding Peptides
Ravishankar, S., Suzuki, S., Sawada, T., Lim, S., & Serizawa, T. (2020) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20200021 · Cited by 7
Azad, N., & Rojanasakul, Y. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-532-9_14 · Cited by 7
Sobczak, M., Olędzka, E., Kwietniewska, M., Nałęcz‐Jawecki, G., & Kołodziejski, W. (2014) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2014.871958 · Cited by 7
Gao, Y., Chen, J., Zhang, X., Xie, H., Wang, Y., & Guo, S. (2016) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmw174 · Cited by 7
Classes of Materials Used in Medicine
Abramson, S. D., Alexander, H., Best, S. M., Bokros, J., Brunski, J., Colas, A., Cooper, S. L., Curtis, J., Haubold, A. D., Hench, L. L., et al. (1996) · Elsevier eBooks · doi:10.1016/b978-012582460-6/50005-0 · Cited by 7
Polysaccharide‐Based Drug Conjugates for Tumor Targeting
Saravanakumar, G., Park, J. H., Kim, K., & Kwon, I. C. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch23 · Cited by 7
Immobilized Thrombolytic Enzymes Possessing Increased Affinity toward Substrate
Torchilin, V. P., Максименко, А. В., Tischenko, E. G., Gv, I., & Ermolin, G. A. (1984) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1984.tb29847.x · Cited by 7
Synthesis and characterization of 2‐acetoxybenzoic acid‐dextran ester conjugates
Sánchez‐Chaves, M., Arranz, F., & Díaz, C. (1989) · Die Makromolekulare Chemie · doi:10.1002/macp.1989.021901005 · Cited by 7
Bridge Bond Formation in Polymer Systems
Krakovyak, M. G., Ananieva, T., & Anufrieva, E. V. (1993) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/15321799308021562 · Cited by 7
Synthesis and biological properties of antitumor-active conjugates of ADR with dextran
Guu, J.-A., Hsiue, G., & Juang, T.-M. (2002) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856202320813846 · Cited by 7
Soyez, H., & Schacht, E. H. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01570-2 · Cited by 7
Dumitriu, S., Popa, M., Dumitriu, M., Dumitriu, D., & Tara, A. (1993) · Journal of Biomaterials Applications · doi:10.1177/088532829300700305 · Cited by 7
Sugiyama, K., & Fukada, S. (1984) · Journal of Polymer Science Polymer Letters Edition · doi:10.1002/pol.1984.130220803 · Cited by 7
Pitha, J., Zjawiony, J. K., Lefkowitz, R. J., & Caron, M. G. (1981) · Die Makromolekulare Chemie · doi:10.1002/macp.1981.021820707 · Cited by 7
Fixation sur cellulose de médicaments libérables par voie enzymatique
Lapicque, F., & Dellacherie, E. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021840204 · Cited by 7
Lee, N., Kim, K.-H., Rhew, H., Choi, W., Chung, I., & Cho, W. (2000) · Polymer International · doi:10.1002/1097-0126(200012)49:12<1702::aid-pi599>3.0.co;2-z · Cited by 7
Hartmann, M., & Klemm, D. (1987) · Zeitschrift für Chemie · doi:10.1002/zfch.19870270102 · Cited by 7
Parodi, A., Khaled, S. M., Yazdi, I. K., Evangelopoulos, M., Furman, N. E. T., Wang, X., Urzi, F., Hmaidan, S., Hartman, K. A., & Tasciotti, E. (2015) · Springer eBooks · doi:10.1007/978-94-007-6178-0_104-2 · Cited by 7
New Oligomers and Polymers as Drug Carriers
Ferruti, P., Angeloni, A. S., Scapini, G., & Tarisi, M. C. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2745-5_5 · Cited by 7
Fan, J. Q., Wu, T., Bu, Y., Chen, X., Ma, T., Yan, H., & Lin, Q. (2025) · Polymer Bulletin · doi:10.1007/s00289-025-05977-z · Cited by 6
“Ringsdorf et al. [108] proposed the concept of polymer-drug covalent coupling in 1975 for the delivery of lipophilic small molecules.”
Rahaman, S. M., Dutta, G., Biswas, R., Sugumaran, A., Salem, M. M., Gamal, M., AbdElrahman, M., & Salem-Bekhit, M. M. (2024) · Acta chimica slovenica · doi:10.17344/acsi.2024.8658 · Cited by 7
Polymer Conjugate as the New Promising Drug Delivery System for Combination Therapy against Cancer
Hu, Q., Zhang, Y., Mukerabigwi, J. F., Wang, H., & Cao, Y. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266280603240321064308 · Cited by 6
Park, K., Otte, A., & Li, T. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00550 · Cited by 6
Casanova, M., Vanelle, P., Azas, N., & Broggi, J. (2024) · Next Materials · doi:10.1016/j.nxmate.2024.100394 · Cited by 7
Polypept(o)ide‐Based Core–Shell Bottlebrush Polymers: A Versatile Platform for Drug Encapsulation
Zhao, B., Wei, J., Berger, R., Jian, L., Koynov, K., Zhang, H., & Barz, M. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500083 · Cited by 6
Troev, K. D. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-416036-1.00001-2 · Cited by 6
Eccleston, M., Williams, S. L., Yue, Z., Chen, R., Lee, C. K., Anikina, E., Pawlyn, C., Barrand, M. A., & Slater, N. K. H. (2005) · Food and Bioproducts Processing · doi:10.1205/fbp.04401 · Cited by 6
Use of New Aminosugar Derivatives as Comonomers for the Synthesis of Glycosylated Poly(Amido-Amines)
Casali, M., Riva, S., & Ferruti, P. (2001) · Journal of Bioactive and Compatible Polymers · doi:10.1106/470q-mbqn-rn2y-lb5l · Cited by 6
Herck, S. V., & Geest, B. G. D. (2020) · Science China Chemistry · doi:10.1007/s11426-019-9705-4 · Cited by 6
RAFT Synthesis of Reactive Multifunctional Triblock‐Copolymers for Polyplex Formation
Ritt, N., Ayaou, A., & Zentel, R. (2021) · Macromolecular Chemistry and Physics · doi:10.1002/macp.202100122 · Cited by 6
Johnson, R. P., & Preman, N. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101997-9.00010-2 · Cited by 7
Ryjpáček, F., Sramek, B. B., Drobnik, J., & Kvetina, J. (1985) · Biomaterials · doi:10.1016/0142-9612(85)90011-0 · Cited by 6
Zhang, L., Fu, J., Xia, Z., Wu, P., & Zhang, X. (2011) · Journal of Applied Polymer Science · doi:10.1002/app.33871 · Cited by 6
Balaure, P. C., Gudovan, D., & Gudovan, I. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-41625-2.00006-5 · Cited by 7
Monteiro, M. J., Sj�berg, M., van der Vlist, J., & G�ttgens, C. M. (2000) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/1099-0518(20001201)38:23<4206::aid-pola60>3.0.co;2-e · Cited by 100
Release of benzocaine, procaine, 2-aminothiazole and 4-amino-4H-1,2,4-triazole from polymer carriers
Kolli, M., Monthéard, J. P., & Vergnaud, J. M. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90001-i · Cited by 6
Fibrinolytic action of an enzyme preparation conjugated with specific antibodies
Torchilin, V. P., Максименко, А. В., Gv, I., Тищенко, Е. Г., Ermolin, G. A., & Smirnov, V. N. (1984) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf00800017 · Cited by 6
Synthesis of Polymer-Drug Conjugates Using Natural Polymer: What, Why and How?
Sagita, E., Syahdi, R. R., & Arrahman, A. (2018) · Pharmaceutical Sciences and Research · doi:10.7454/psr.v5i3.4376 · Cited by 9
“Ringsdorf’s model is the generic concept of polymer-drug conjugates design with lysosomotropic system, which was established in 1975 by Helmut Ringsdorf (Ringsdorf, 1975).”
BackgroundProdrugs and Drug Delivery Systems
Silverman, R. B. (1992) · Elsevier eBooks · doi:10.1016/b978-0-08-057123-2.50012-0 · Cited by 6
Metabolic Considerations in Prodrug Design
Balant, L. P. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc034 · Cited by 6
Metadata
- Authors
- Ringsdorf, H.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Ringsdorf, Helmut
- Venue
- Journal of Polymer Science: Polymer Symposia
- Publisher
- Wiley
- Published
- 1975-01
- Volume
- 51
- Issue
- 1
- Pages
- 135-153
- ISSN
- 0360-8905 (ISSN-L)
- 1936-0959
- OpenAlex
- W2098279377
- Cited by
- 1,094
- References
- 63
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 34 · 2023: 35 · 2022: 30 · 2021: 35 · 2020: 50 · 2019: 36 · 2018: 29 · 2017: 46 · 2016: 45 · 2015: 47 · 2014: 55 · 2013: 43 · 2012: 48
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Polymer Science Polymer Symposia (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- macromolecular drugs, comonomer incorporation, polymer-analogous reactions, solubility, toxicity, body distribution, polymer synthesis, biological activity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.